TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ALC

Alcon Inc. Ordinary Shares

NYSE
$74.31
▲ $6.48 (+9.6%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 20 Nov 2026
H $77.85L $62.10+16.8%
$77.85$74.7$71.55$68.4$65.25$62.1$74.31
RSI (14)
Intraday · 15-minSell-15RSI 44DowntrendMACD Bullishfor day-trading context — not advice

Technical signal

Buy+30
RSI (14)58
oversold 30overbought 70
Trend
Uptrend
MACD
Bearish
Bollinger
Within bands
vs 20-day
above
vs 50-day
above
vs 200-day
above
Support
$68.82
Resistance
$77.85
  • Price is above its 50-day average (medium-term uptrend).
  • Price is above its 200-day average (long-term uptrend).

Signal backtest · 2026-02-20 → 2026-11-20

Strategy return
-6.5%
Buy & hold
-10.1%
Trades
5
Win rate
20%

$100,000.00 invested would be worth $93,477.68 (-6.5%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Alcon Inc.· Medical Instruments & Supplies

source: yahoo

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
25,000
Headquarters
Geneva, Switzerland

Fundamentals

source: yahoo
Market cap
$35.7B
P/E
54.2
P/B
1.6
EPS
$1.37
Div yield
0.5%
Profit margin
6.1%
ROE
3.0%
Debt / Equity
0.25
Beta
0.72
52-week range
$61.84 – $87.64
52-week low · $61.8448% of rangehigh · $87.64

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▲ Positive2↑ · 1↓ · 5–
  • What Drove Glaukos Stock's 48% Rally Since the End of September?▲ Positive
    Zacks · 18 Nov 2026
  • Bill Ackman's Latest Filing Shows Two Big Bets Beyond Streaming Stocks— Neutral
    GuruFocus.com · 17 Nov 2026
  • Bill Ackman Adds More To Netflix In Q3; Exits Hertz, Cuts Microsoft▼ Negative
    Stocktwits · 17 Nov 2026
  • Are Q3 Results Altering The Investment Case For Alcon (SWX:ALC)?

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

www.alcon.com ↗
— Neutral
Simply Wall St. · 12 Nov 2026
  • Alcon (SWX:ALC) Stock Could Be 47% Undervalued After Neurotech Acquisition— Neutral
    Simply Wall St. · 12 Nov 2026
  • What Could Alcon (SWX:ALC) Q3 Sales And New Deal Mean For Growth?▲ Positive
    Simply Wall St. · 12 Nov 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.